These findings indicate that NF-κB activity in the BLA is required for memory reconsolidation in AFC, suggesting that NF-κB might be a potential pharmacotherapy target for posttraumatic stress disorder. The gene discussed is NFKB1; the disease is post-traumatic stress disorder.